company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,83980000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,83980000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10084000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10084000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,73896000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,49371000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28646000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,78017000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4121000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3248000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1297000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,529000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1422000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5543000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3199000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2344000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2344000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2344000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52982000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52982000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58600000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:01:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,97215000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,97215000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12755000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12755000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,84460000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41172000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31551000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72723000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11737000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3331000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1043000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-403000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2691000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9046000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2891000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11937000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11937000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11937000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53455000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.22
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57653000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54300000.0
United Therapeutics Corp,UTHR,,0001082554,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:02:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,128880000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,128880000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14886000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14886000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,113994000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,46877000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34871000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,81748000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,32246000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4687000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,897000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,225000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3565000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,28681000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9752000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18929000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18929000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18929000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54769000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.35
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60019000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.32
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54100000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 07:02:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.35
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,137491000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,137491000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16684000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16684000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,120807000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,31036000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28944000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59980000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,60827000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4759000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,758000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,93000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3908000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,56919000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19212000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37707000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,37707000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,37707000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56047000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.67
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60393000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.62
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56300000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q2,2010-04-01,2010-06-30,2010-07-28 07:01:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.67
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,170983000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,170983000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21722000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21722000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,149261000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,46689000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40691000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,87380000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,61881000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4809000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,525000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,137000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4147000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,57734000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17998000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,39736000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,39736000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,39736000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56536000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.7
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60216000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.66
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56800000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q3,2010-07-01,2010-09-30,2010-10-28 07:02:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.7
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,154348000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1197000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,155545000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14382000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14382000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,141163000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,64004000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,60800000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,124804000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16359000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5455000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,599000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,314000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4542000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11817000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3017000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14834000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-5290000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9544000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9544000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56142000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59516000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56000000.0
United Therapeutics Corp,UTHR,,0001082554,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,165619000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,165619000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21471000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21471000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,144148000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,59235000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48030000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,107265000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,36883000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5413000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,629000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5273000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10057000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,26826000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10436000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16390000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16390000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16390000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57753000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.28
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62623000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.26
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58500000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q1,2011-01-01,2011-03-31,2011-04-28 07:02:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.28
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,183751000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,183751000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21162000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21162000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,162589000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23856000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24240000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48096000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,114493000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5431000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,809000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-257000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4879000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,109614000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,35723000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,73891000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,73891000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,73891000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58180000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.27
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62756000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.18
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58200000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q2,2011-04-01,2011-06-30,2011-07-28 07:01:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.27
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,201020000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,722000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,201742000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22676000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22676000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,179066000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16656000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,59433000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,76089000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,102977000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5416000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,973000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-278000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4721000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,98256000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17641000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,80615000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,3783000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,84398000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,84398000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58321000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.45
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61210000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.38
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58200000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q3,2011-07-01,2011-09-30,2011-10-27 07:01:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.45
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,190704000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1367000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,192071000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23595000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23595000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,168476000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56735000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48312000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,105047000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,63429000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5107000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1039000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5060000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,992000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,64421000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18074000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,46347000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-3158000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,43189000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,43189000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57163000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.81
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59395000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.85
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57200000.0
United Therapeutics Corp,UTHR,,0001082554,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.81
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,202943000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1271000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,204214000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24031000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24031000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,180183000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39789000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33657000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,73446000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,106737000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3886000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1013000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,72000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2801000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,103936000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,33176000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,70760000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,70760000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,70760000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53631000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.32
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55009000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.29
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53600000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 06:05:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.32
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,221832000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3745000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,225577000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29633000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29633000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,195944000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,53258000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37099000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,90357000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,105587000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3879000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1013000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,569000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2297000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,103290000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,30974000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,72316000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,72316000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,72316000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52747000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.37
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53942000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.34
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52800000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 06:05:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.37
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,240917000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1551000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,242468000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27968000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27968000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,214500000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,68626000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,65155000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,133781000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,80719000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4384000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1138000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,31020000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,27774000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,108493000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,30382000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,78111000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,78111000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,78111000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51514000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.52
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53590000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.46
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51400000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 06:06:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.52
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,240431000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3386000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,243817000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,37665000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,37665000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,206152000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40073000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37476000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,77549000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,128603000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4490000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,777000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,62000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3651000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,124952000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,41697000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,83255000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,83255000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,83255000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52093000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.63
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53280000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.62
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52100000.0
United Therapeutics Corp,UTHR,,0001082554,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.63
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,243146000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1990000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,245136000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29313000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29313000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,215823000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,71356000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,50430000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,121786000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,94037000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4436000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,932000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,302000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3202000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,90835000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,28510000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,62325000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,62325000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,62325000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50209000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.24
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52376000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.19
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50300000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 06:05:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.24
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,277495000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3111000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,280606000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,32320000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,32320000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,248286000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,71365000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,54617000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,125982000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,122304000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4520000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,797000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-62000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3785000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,118519000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,38655000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,79864000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,79864000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,79864000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49800000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.6
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52648000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.52
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49900000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 06:05:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.6
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,300006000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2219000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,302225000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30716000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30716000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,271509000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,94111000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,72749000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,166860000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,104649000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4540000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,868000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,202000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3470000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,101179000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,38494000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,62685000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,62685000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,62685000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50014000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.25
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53688000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.17
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50100000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q3,2013-07-01,2013-09-30,2013-10-29 06:06:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.25
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,286297000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2720000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,289017000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,38778000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,38778000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,250239000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,157178000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,121552000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,278730000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28491000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4562000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2597000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4020000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3139000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31630000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1316000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30314000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30314000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30314000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50076000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.6
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53231000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.6
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50000000.0
United Therapeutics Corp,UTHR,,0001082554,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.6
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,284553000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,4850000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,289403000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30600000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30600000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,258803000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30215000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12448000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42663000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,216140000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4610000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1232000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,454000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2924000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,213216000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,75692000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,137524000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,137524000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,137524000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50402000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.73
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56657000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.43
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50400000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q1,2014-01-01,2014-03-31,2014-04-29 06:01:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.73
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,321329000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1473000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,322802000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,38709000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,38709000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,284093000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,68031000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39742000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,107773000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,176320000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4746000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1459000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3287000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,173033000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,61181000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,111852000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,111852000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,111852000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47617000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.35
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53252000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.1
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47600000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q2,2014-04-01,2014-06-30,2015-07-28 06:04:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.35
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,328269000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1681000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,329950000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,40803000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,40803000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,289147000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,202507000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,118876000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,321383000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32236000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4709000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1112000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3597000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35833000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-10596000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25237000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25237000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25237000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47297000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.53
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47297000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.53
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47600000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 06:01:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.53
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,345349000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,996000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,346345000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15788000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15788000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,330557000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,80547000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,71434000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,151981000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,178576000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3535000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1232000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,975000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3792000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,174784000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,58823000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,115961000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,115961000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,115961000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48200000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.51
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54200000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.28
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48200000.0
United Therapeutics Corp,UTHR,,0001082554,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.51
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,325900000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1600000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,327500000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20800000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20800000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,306700000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,211300000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,110200000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,321500000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14800000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2100000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,100000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2000000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16800000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-200000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16600000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16600000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16600000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46700000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46700000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46100000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 06:05:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,345800000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1400000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,347200000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16000000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16000000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,331200000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,110000000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49400000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,159400000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,171800000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1300000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2100000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3400000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,168400000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,69200000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,99200000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,99200000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,99200000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46100000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.15
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51900000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.91
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46100000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 06:01:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.15
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,384700000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1500000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,386200000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6900000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6900000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,379300000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-17300000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9600000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-7700000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,387000000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,800000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,350600000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,349800000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,736800000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,272400000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,464400000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,464400000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,464400000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45500000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,10.2
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50200000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,9.24
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45500000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 06:02:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,10.2
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,404200000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,700000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,404900000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25300000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25300000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,379600000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,148700000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,75900000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,224600000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,155000000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,500000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1500000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1000000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,156000000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,51400000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,104600000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,104600000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,104600000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46000000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.18
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51200000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.93
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46000000.0
United Therapeutics Corp,UTHR,,0001082554,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.18
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,369000000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,369000000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,700000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,700000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,368300000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5000000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-400000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4600000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,363700000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,600000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,800000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,200000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,363900000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,128400000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,235500000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,235500000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,235500000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45400000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.19
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48700000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.84
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45400000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 06:03:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.19
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,412600000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,412600000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20000000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20000000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,392600000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,72200000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35200000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,107400000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,285200000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,600000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1100000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,500000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,285700000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,79600000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,206100000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,206100000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,206100000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44300000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.65
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46900000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.39
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44300000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 06:03:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.65
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,408200000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,408200000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23600000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23600000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,384600000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,100100000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45900000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,146000000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,238600000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,500000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1000000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,500000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,239100000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,77300000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,161800000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,161800000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,161800000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43200000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.75
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46200000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.5
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43100000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 06:04:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.75
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,409000000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,409000000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28400000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28400000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,380600000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,139500000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,66900000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,206400000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,174200000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2200000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3500000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2700000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,171500000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,61200000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,110300000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,110300000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,110300000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43800000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.7
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46800000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.52
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43800000.0
United Therapeutics Corp,UTHR,,0001082554,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.7
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,370500000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,370500000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14300000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14300000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,356200000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56400000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36200000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,92600000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,263600000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,800000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,800000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,263600000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,85000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,178600000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,178600000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,178600000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44500000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.01
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45900000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.89
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44500000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 06:03:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.01
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,444600000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,444600000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18900000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18900000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,425700000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,67400000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,59800000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,210000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,337200000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,88500000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1400000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-42900000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-44300000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,44200000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,100200000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-56000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-56000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-56000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44900000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.25
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44900000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.25
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44800000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 06:03:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.25
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,445500000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,445500000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19500000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19500000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,426000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,47200000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,55000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,102200000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,323800000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3300000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2200000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3100000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,320700000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,44400000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,276300000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,276300000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,276300000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43400000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,6.37
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44100000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.27
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43400000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 06:03:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.37
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,464700000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,464700000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,53000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,53000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,411700000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,159100000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,113600000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,272700000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,139000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3500000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8700000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3200000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,141000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,122000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,19000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,19000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.37
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44900000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44000000.0
United Therapeutics Corp,UTHR,,0001082554,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.37
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,389200000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,389200000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,53200000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,53200000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,336000000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-6600000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35700000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29100000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,306900000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2600000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5300000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-600000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2100000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,309000000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,64500000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,244500000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,244500000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,244500000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43300000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.65
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43900000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.57
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43300000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 06:02:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.65
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,444500000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,444500000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,61700000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,61700000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,382800000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,83100000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,82300000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,165400000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,217400000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2900000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6700000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3300000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,500000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,217900000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,45000000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,172900000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,172900000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,172900000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43100000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.01
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43400000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.98
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43100000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 06:07:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.01
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,412700000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,412700000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,51900000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,51900000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,360800000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,110100000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,101100000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,211200000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,149600000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4100000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7900000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-13300000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9500000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,140100000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,33600000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,106500000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,106500000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,106500000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43600000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.44
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44000000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.42
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43600000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q3,2018-07-01,2018-09-30,2019-10-30 06:17:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.44
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,381400000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,381400000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31900000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31900000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,349500000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,79200000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,138800000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,218000000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,131500000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4300000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8700000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-44000000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39600000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,91900000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26600000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,65300000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,65300000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,65300000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43500000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.44
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44000000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.42
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43500000.0
United Therapeutics Corp,UTHR,,0001082554,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.44
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,362600000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,362600000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29100000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29100000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,333500000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,92000000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,897400000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,989400000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-655900000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10300000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9800000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5800000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5300000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-650600000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-156000000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-494600000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-494600000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-494600000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43700000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-11.32
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43700000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-11.32
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43700000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 06:13:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-11.32
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,373600000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,373600000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,26700000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,26700000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,346900000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39600000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,85900000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,125500000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,221400000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12200000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10800000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,30400000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,29000000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,250400000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,45300000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,205100000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,205100000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,205100000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43800000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.68
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44000000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.66
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43800000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q2,2019-04-01,2019-06-30,2019-07-31 06:07:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.68
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,401500000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,401500000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,33000000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,33000000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,368500000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,99400000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,85700000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,185100000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,183400000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11700000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12100000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-16900000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16500000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,166900000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,34500000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,132400000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,132400000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,132400000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43900000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.02
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44000000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.01
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43800000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 06:17:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.02
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,311100000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,311100000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28800000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28800000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,282300000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,105200000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,113600000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,218800000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,63500000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10000000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,11500000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3300000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4800000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,68300000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15700000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,52600000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,52600000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,52600000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43800000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.23
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43800000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.26
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43700000.0
United Therapeutics Corp,UTHR,,0001082554,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.23
